|
Volumn 21, Issue 3, 2012, Pages 159-162
|
INTERIM Guidelines for the Diagnosis and Management of Familial Hypercholesterolaemia
|
Author keywords
Familial hypercholesterolaemia; Family cascade screening; LDL receptor mutation; Monogenic
|
Indexed keywords
EZETIMIBE;
FIBRIC ACID DERIVATIVE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
STEROL REGULATORY ELEMENT BINDING PROTEIN;
ARTICLE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL FEATURE;
FAMILIAL HYPERCHOLESTEROLEMIA;
FEMALE;
GENE MUTATION;
GENETIC COUNSELING;
GENETIC DISORDER;
GENETIC SCREENING;
HUMAN;
MALE;
MOLECULAR GENETICS;
MORTALITY;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
RISK FACTOR;
ANTICHOLESTEREMIC AGENTS;
GENETIC TESTING;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPOPROTEINEMIA TYPE II;
MUTATION;
RISK FACTORS;
|
EID: 84857488169
PISSN: 14439506
EISSN: 14442892
Source Type: Journal
DOI: 10.1016/j.hlc.2011.11.006 Document Type: Article |
Times cited : (12)
|
References (6)
|